These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 18049944)

  • 1. Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists.
    Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; Palacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M
    Climacteric; 2007 Dec; 10(6):508-26. PubMed ID: 18049944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists.
    Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; Palacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M
    Eur Heart J; 2007 Aug; 28(16):2028-40. PubMed ID: 17644507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopause management: a cardiovascular risk-based approach.
    Haines CJ; Farrell E
    Climacteric; 2010 Aug; 13(4):328-39. PubMed ID: 20001565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention.
    Vitale C; Miceli M; Rosano GM
    Climacteric; 2007 Oct; 10 Suppl 2():16-20. PubMed ID: 17882667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of hormone replacement therapy on metabolic syndrome components in perimenopausal women.
    Korljan B; Bagatin J; Kokić S; Berović Matulić N; Barsić Ostojić S; Deković A
    Med Hypotheses; 2010 Jan; 74(1):162-3. PubMed ID: 19665311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing cardiovascular risk in menopausal women.
    Rosano GM; Vitale C; Tulli A
    Climacteric; 2006 Sep; 9 Suppl 1():19-27. PubMed ID: 16899440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in hormone replacement therapy: perceptions and usage.
    Birkhäuser MH; Reinecke I
    Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perimenopausal knowledge of mid-life women in northern Taiwan.
    Tsao LI; Chang WY; Hung LL; Chang SH; Chou PC
    J Clin Nurs; 2004 Jul; 13(5):627-35. PubMed ID: 15189416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy in the WHI era.
    Burger HG
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):84-91. PubMed ID: 16638027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of cardiovascular risk in the peri-menopausal woman--a consensus statement of European cardiologists and gynaecologists].
    Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; Palacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M
    Kardiol Pol; 2007 Nov; 65(11):1331-46; discussion 1347-49. PubMed ID: 18303601
    [No Abstract]   [Full Text] [Related]  

  • 15. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
    Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM;
    Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal hormone therapy: currently no evidence for cardiac protection.
    Wenger NK
    Pediatr Blood Cancer; 2005 Jun; 44(7):625-9. PubMed ID: 15747336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
    Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
    Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The attitude of gynecologists in São Paulo, Brazil 3 years after the Women's Health Initiative study.
    Lazar F; Costa-Paiva L; Morais SS; Pedro AO; Pinto-Neto AM
    Maturitas; 2007 Feb; 56(2):129-41. PubMed ID: 16901660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.